Citigroup’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Citigroup's RXST Position: Q1 2026 in Review
Citigroup increased its RxSight (RXST) stake by 129% in Q1 2026, buying an estimated $9.6K and bringing the position to 2,049 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4958.
Citigroup first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.19M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Citigroup held 2,049 shares of RxSight worth $12.6K as of Q1 2026.
- Citigroup bought 1,156 RxSight shares in Q1 2026, an estimated $9.6K.
- RxSight made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4958 holding.
- Citigroup first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- Citigroup's RxSight position peaked at $2.19M in Q4 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.